Burning Rock Biotech (BNR) Current Leases (2019 - 2025)

Burning Rock Biotech's Current Leases history runs 7 years deep, the most recent figure standing at $2.4 million for Q4 2025.

• In Q4 2025, Current Leases fell 30.9% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $2.4 million (down 30.9% YoY), while the FY2025 annual figure was $2.4 million, down 28.79% from the prior year.
• Current Leases was $2.4 million for Q4 2025 at Burning Rock Biotech, up from $2.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $5.7 million in Q2 2022 to a low of $1.2 million in Q4 2023.
• Historically, Current Leases has averaged $3.8 million across 5 years, with a median of $3.8 million in 2024.
• The sharpest annual moves came in 2021 and 2023: Current Leases surged 653.29% in 2021, then tumbled 77.1% in 2023.
• A 5-year view of Current Leases shows it stood at $5.5 million in 2021, then decreased by 4.36% to $5.2 million in 2022, then sank by 77.1% to $1.2 million in 2023, then jumped by 185.21% to $3.4 million in 2024, then slumped by 30.9% to $2.4 million in 2025.
• The last three Current Leases figures came in at $2.4 million (Q4 2025), $2.3 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.